Gilenya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Safety and Effectiveness of Generic Fingolimod (Sphingomod ®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
Condition:   Relapsing-Remitting Multiple Sclerosis Intervention:   Drug: Fingolimod Sponsor:   Hikma Pharmaceuticals LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2022 Category: Research Source Type: clinical trials

Fingolimod for Type 2 Diabetes Mellitus
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Fingolimod;   Drug: guideline-based treatment for DM Sponsor:   General Hospital of Shenyang Military Region Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2022 Category: Research Source Type: clinical trials